Boothbay Fund Management, LLC Next Cure, Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.38 - $5.27 $45,528 - $70,986	-13,470 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.7 - $9.1 $214,827 - $342,969	-37,689 Reduced 73.67%	13,470 $81,000
Q3 2021 Nov 15, 2021	SELL	$6.74 - $8.02 $84,924 - $101,052	-12,600 Reduced 19.76%	51,159 $345,000
Q2 2021 Aug 16, 2021	BUY	$7.6 - $10.28 $91,732 - $124,079	12,070 Added 23.35%	63,759 $512,000
Q1 2021 May 17, 2021	BUY	$9.81 - $13.88 $281,556 - $398,369	28,701 Added 124.85%	51,689 $517,000
Q3 2020 Nov 16, 2020	BUY	$8.15 - $21.17 $187,352 - $486,655	22,988 New	22,988 $202,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $26.9M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.